跳至主要内容
临床试验/IRCT2016110330678N1
IRCT2016110330678N1已完成未知

The effect of metacognitive therapy in patient with schizophrenia

Vice chancellor for research, Tehran University of Medical Sciences0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
All

入选标准

  • Age 18 to 45 years; diagnosis of schizophrenia according to The Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 is approved by the psychiatrist's interview; Be educated at least secondary school (8 years); The patient has positive symptoms (symptoms are moderate to high in the initial tests); no change in medication over the past month and in the last two months has not received ECT; patient's condition is stable and no acute psychosis
  • Exclusion criteria: Borderline intellectual functioning or mental retardation based on the history and interviews; Drug or alcohol; Severe neurological disease (epilepsy, Parkinson's, dementia, Multiple sclerosis and any movement disorder); Forms of thought disorder, Hostility and extreme aggression; In case of worsening of symptoms or need to change the medication

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tehran University of Medical Sciences

相似试验